XML 51 R41.htm IDEA: XBRL DOCUMENT v3.20.2
License and Collaboration Agreements - Additional Information (Details) - Apollomics, Inc.
$ in Millions
1 Months Ended
Jan. 31, 2020
USD ($)
Research and License Agreements  
Up-front payment received $ 9.0
Milestones based on achievement of certain clinical and regulatory events 75.0
Milestone payment upon achievement of specified net sales thresholds for all licensed products $ 105.0
Maximum  
Research and License Agreements  
Tiered percentage of annual net sales 15.00%